Renal Action of BRL 34915, a $K^+$ Channel Opener, in Dog

$K^+$ Channel 개방제인 BRL 34915의 신장작용

  • Published : 2000.06.01

Abstract

The effect of BRL 34915, a $K^{+}$ channe$Na^{+}$l opener, on renal function was investigated in anesthetized dog. BRL 34915, when given into the vein, elicited the decrease of urine volume accompanied with the reduction of renal plasma flow (RPF), osmolar clearance ($C_{osm}$) and amounts of sodium excreted into urine ($E_{na}$), whereas reabsorption rate of sodium in renal tubules ($R_{na}$), ratio of $K^{+}$ against $Na^{+}$ in urine ($K^{+}$ /$Na^{+}$) were elevated significantly with a partial fall of mean arterial pressure (MAP). BRL 34915 injected into a renal artery produced the diuretic action along with the increase in RPF $C_{osm}$, $E_{na}$ and amounts of potassium excreted in urine ($E_{k}$), and the decrease in $R_{na}$, reabsorption rate of potassium in renal tubules ($R_{k}$), free water clearance ($C_{H20}$) and $K^{+}/Na^{+}$ ratio in only ipsilateral kidney, however changes of the renal function were not observed in control kidney. BRL 34915 given into carotid artery exhibited the same aspect as changes of renal function induced by intravenous BRL 34915. These results suggest that BRL 34915 has dual effects, renally acting diuretic and centrally acting antidiuretic action.n.

Keywords

References

  1. Br. J. Pharmacol. v.93 Studies on the anti-vasoconstrictor activity of BRL 34951 in spontaneously hypertensive rats: a comparison with nifedipine Buckingham. R.E.
  2. J. Cardiovasc. Pharmacol. v.11 Similarties in the mechanism of action of two new vasodilator drugs: Pinancidil and BRL 34915 Cook. N.S.;Quast. U.;Hof. R.P.;Baumlin. Y.;Pally. C.
  3. J. Hypertens v.4 no.SUP6 Potassium channel activators lower blood pressure: An intial study of BRL 34915 in hypertensive patients VandenBurg. M.J.;Woodward. S.R.;Hossain. M.;Stewart-Long. P.;Tasker. T.C.G.
  4. Br. J. Pharmacol. v.88 Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein Hamilton. T.C.;Weir. S.W.;Weston. A.H.
  5. Br. J. Pharmacol. v.88 The effects of BRL 34915 and nicorandil on electrical and mechanical actibity an on 86RB+ efflux in rat blood vessels Weir. S.W.;Weston. A.H.
  6. Eur. J. Pharmacol v.152 Comparative effects of K+-channel blocker on the vasorelaxant activity of cromakalim , pinacidil and nicorandil Wilson. C.;Coldwell. M.C.;Howlett. D.R.;Cooper. S.M.;Hamilton. T.C.
  7. Br. J. Pharmacol v.91 Effect of the K+ efflux stimulating vasodilator BRL 34951 on 86RB+ efflux and spontaneous activity in guinea-pig portal vein Quast. U.
  8. Naunynschmiedeberg's Arch. Pharmacol v.338 Comparison of the effluxes of 42K+ and 86Rb+ elicited by cromakalim(BRL 34915)in tonic and phasic vascular tissue Quat. U.;Baumlin. Y.
  9. Br. J. Pharmacol. v.100 The action of diazoxide and minoxidil sulfate on rat blood vessels a comparison with BRL 34915 Neugreen. D.T.;Bray. K.M.;McHarg. A.D.;Weston. A.H.;Dutdy. S.;Brown. P.S.;Kay. P.B.;Edwards. G.;Longmore. J.;Southereon. S.
  10. J. Pjharmacol. Expt. Ther. v.261 The inhibitory effects of BRL 34915 and its active enatiomer BRL 38227 against various agonists in guniea pig and human airway: Comparison with pinacidil and verapamil Taylor. S.G.;Arch. J.R.S.;Boond. J.;Buckle. D.R.;Shaw. D.J.;Taylor. J.E.;Ward. J.S.
  11. J. Pharmacol. Exp. Ther. v.252 Effects of BRL 34915 on renal hemodynamics and function in anesthetized dogs Hayashi. K.;Matsumura. Y.;Yoshida. Y.;Ohyama. T.;Hisaki. K.;Suzuki. Y.;Morimoto. S.
  12. J. Pharmacol. Exp. Ther. v.250 In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim and their inhibitor by glybenclamide Quast. U.;Cook. N.S.
  13. Baltimore, Wiliams, Wilkins v.2 Quantitative Clinical Chemistry by Peters and Van Slyke Phillips. B.A.
  14. J. Clin. Invest. v.21 The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man Smith. H.W.;Finkelstein. N.;Aliminosa. L.;Crawford. B.;Graber. B.
  15. Statistical Methods (7th eds.) Snedecor. G.W.;Cochran. W.G.
  16. J. Pharmacol. Exp. Ther. v.265 Unique natriuretic properties of the ATP-sensitive K+ channel blocker glyburide in concious rats Clark. M.A.;Hunphrey. S.J.;Smith. M.P.;Ludens. J.H.
  17. Annu. Rev. Physiol v.54 Renal potassium channels and their regulation Wang. W.;Sackin. H.;Geibisch. G.
  18. J. Clin. Inverst. v.44 The site of action of furosemide and other sulfonamide diuretics in the dog Suki. W.;Rector. E.C.;Selin. D.W.
  19. Journal of RIMSK v.2 Formation and excretion of urine Gill. W.S.
  20. Am. J. physiol. v.234 Renal autoregulation: Perspectives from whole kidney and single nephron studies Navar. L.G.
  21. Supp. 1. Circ. Res. v.40 Neurogenic control of renal tubular sodium rebsorption in the dog Di Bona. G.H.;Zambraski. E.J.;Aguilera. A.J.;Karloyanides. G.J.
  22. Permeability of the blood-brain barrier. In The Nervours System, Vol. : The Basic Neurosciences Oldendroff. W.H.;Tower. D.B.(ed.)